Lamin A/C Treatment Titin Diagnosis Joint laxity INPP5K Regeneration Next generation sequencing COL6A1 LMNA-related congenital muscular dystrophy Biological sciences Skeletal muscle Cardiac conduction system Myogenesis Dilated cardiomyopathy Centronuclear myopathy GNE COL1A1 COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Clinical trial Hypermobile EDS Lamin A/C LMNA gene IPSC Myologie LMNA gene Mouse Allele-specific silencing therapy Nuclear envelope Lamins Exome CSF protein A-type lamin Becker muscular dystrophy POPDC1 Autophagosome maturation Cancer biomarkers Treatment delay Biomarker Muscle biopsy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Adult SMA Alternative splicing Muscular dystrophy BiP Mutations Laminopathies Gene therapy Muscular dystrophy MD Myotubes Angiotensin-converting enzyme inhibitor Rare diseases Muscle C2C12 Dynamin 2 A-type lamins Duchenne muscular dystrophy Connective tissue Heart failure Laminopathie Base de données FAIR Acetyltransferase AAV VECTOR Ehlers‐Danlos Syndrome Maladies rares Rare neuromuscular diseases Calcium handling CRISPR Allele‐specific silencing therapy Butyrylcholinesterase Lamin A/C nuclei Cardiomyopathy Emery-Dreifuss muscular dystrophy Laminopathy COVID-19 BVES CMTX AAV Maladies rares et orphelines Dystrophie musculaire Myopathy RNA interference Errance diagnostique Myopathies Cancer Heart LGMD LMNA Cardiology Dystrophine Actionable gene Emerin Congenital muscular dystrophy Therapy C elegans Actionability Neuromuscular diseases Angiotensin-converting enzyme inhibitors Patient registry Muscle MRI Allele-specific silencing